Cellulitishttps://sw.wikipedia.org/wiki/Selulitisi
Cellulitis ni maambukizi ya bakteria yanayohusisha tabaka za ndani za ngozi. Kama ishara na dalili, eneo lenye uchungu la uwekundu huongezeka kwa ukubwa kwa siku chache. Mipaka ya eneo la uwekundu kwa ujumla haijatengwa vizuri na ngozi inaweza kuvimba. Eneo la maambukizi ni kawaida chungu. Mtu anaweza kuwa na homa na myagia.

Miguu na uso ni maeneo ya kawaida yanayohusika. Sababu za hatari ni pamoja na fetma, uvimbe wa mguu, na uzee. Bakteria zinazohusika zaidi ni streptococci na Staphylococcus aureus.

Matibabu kwa kawaida hufanywa kwa kutumia viuavijasumu kwa mdomo, kama vile cephalexin, amoksilini au cloxacillin. Takriban 95% ya watu ni bora baada ya siku 7 hadi 10 za matibabu. Wale walio na ugonjwa wa kisukari, hata hivyo, mara nyingi huwa na matokeo mabaya zaidi.

Cellulitis ni ugonjwa wa kawaida, na huko Uingereza, seluliti ndio sababu ya 1.6% ya kulazwa hospitalini. Cellulitis mnamo 2015 ilisababisha vifo vipatavyo 16,900 ulimwenguni.

○ Matibabu - Dawa za OTC
Cellulitis ya juu inahitaji matibabu na antibiotics iliyowekwa tu na daktari. Ikiwa kidonda kinaendelea kwa kasi na kinafuatana na homa na baridi, inashauriwa kuona daktari haraka iwezekanavyo.
Kuweka marashi ya antibiotiki ya dukani kwa vidonda vya mapema kunaweza kusaidia. Ikiwa mafuta yanatumiwa nyembamba sana, huenda yasifanye kazi kabisa.
#Polysporin
#Bacitracin
#Betadine

Tumia dawa za kutuliza maumivu za OTC kama vile acetaminophen ili kupunguza maumivu.
#Ibuprofen
#Naproxen
#Acetaminophen

Weka miguu safi na kutibu mguu wa mwanariadha kwa sababu mguu wa mwanariadha huongeza hatari ya selulosi.

○ Matibabu
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)
☆ Katika matokeo ya 2022 ya Stiftung Warentest kutoka Ujerumani, kuridhika kwa watumiaji na ModelDerm kulikuwa chini kidogo kuliko na mashauriano ya matibabu ya simu yanayolipishwa.
  • Mguu ni eneo la kawaida kwa Cellulitis.
  • Kesi ya kawaida
  • Cellulitis ― hatua ya uponyaji
  • Cellulitis kwenye mguu wa kushoto. Ikiwa inaenea sana, homa kubwa inaweza kutokea, na kusababisha mshtuko wa septic unaohatarisha maisha.
  • Wakati kidonda kinaboresha, hyperpigmentation baada ya uchochezi inaweza kuonekana.
  • Inaweza kusababishwa na jeraha kwenye kiganja.
  • Kesi ya kawaida
  • Iwapo kibandiko chenye chembe chembe chembe chembe cha joto kikienea haraka, Cellulitis inapaswa kushukiwa.
  • Cellulitis inapoimarika, seli za ngozi zilizokufa zinaweza kuchubuka na kuwashwa.
  • Nyingi Cellulitis huambatana na uvimbe na erithema katika eneo jirani. Walakini, katika kesi hii ya kipekee ambapo hakuna erithema inayozunguka, saratani ya seli ya squamous inapaswa pia kushukiwa.
  • Kesi ya kawaida
  • Awamu ya uponyaji.
References Cellulitis 31747177 
NIH
Cellulitis ni maambukizi ya ngozi ya kawaida ya bakteria. Inaathiri zaidi ya watu milioni 14 kila mwaka nchini Merika. Inaongoza kwa takriban dola bilioni 3. 7 katika gharama za utunzaji wa wagonjwa na kulazwa hospitalini 650,000 kila mwaka. Kwa kawaida, cellulitis huonekana kama sehemu yenye joto, nyekundu kwenye ngozi yenye uvimbe na upole. Husababishwa na maambukizi ya ghafla ya bakteria ambayo huchochea uvimbe kwenye tabaka za kina za ngozi na tishu zilizo karibu. Hakuna jipu au usaha na maambukizi haya. Beta-hemolytic streptococci, hasa kundi A streptococcus (Streptococcus pyogenes) , ndio wahalifu wa kawaida, ikifuatiwa na methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
 Cellulitis: current insights into pathophysiology and clinical management 29219814
Cellulitis ni maambukizi ya bakteria kwenye ngozi na tishu laini. Hutokea wakati kuna matatizo na kizuizi cha kinga ya ngozi, mfumo wa kinga, au mzunguko wa damu. Kisukari, unene, na uzee huongeza uwezekano wa cellulitis kwa kuathiri maeneo haya. Pia tunaangalia matokeo ya hivi majuzi kuhusu utambuzi cellulitis , tukiangazia umuhimu wa utambuzi sahihi kwa kuwa hali kama vile upungufu wa vena, ukurutu, thrombosi ya mshipa wa kina, na gout mara nyingi huchanganyikiwa na seluliti. Viuavijasumu vinavyotumika kutibu cellulitis huchaguliwa kwa uangalifu ili kulenga bakteria wa kawaida bila kuhimiza ukinzani wa viuavijasumu. Pia tunazungumza kuhusu viua vijasumu vipya vilivyoidhinishwa kwa cellulitis. Cellulitis mara nyingi hurudi kwa sababu ya sababu za hatari zinazoendelea na uharibifu wa mfumo wa lymphatic.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
 Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Watu wengi huenda hospitalini au vyumba vya dharura kwa maambukizi ya ghafla ya ngozi ya bakteria. Staphylococcus aureus ndicho kidudu kikuu kinachosababisha maambukizi haya, na inakuwa vigumu kutibu kwa sababu baadhi ya aina hustahimili viuavijasumu vya kawaida.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus inaweza kugawanywa katika aina mbili kulingana na majibu yao kwa antibiotics: methicillin-sensitive Staphylococcus aureus (MSSA) , methicillin-resistant Staphylococcus aureus (MRSA) . Katika miongo michache iliyopita, kutokana na mabadiliko ya bakteria na matumizi kupita kiasi ya viuavijasumu, upinzani wa S. Aureus kwa dawa umekuwa ukiongezeka, na kusababisha ongezeko la kimataifa la MRSA viwango vya maambukizi.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.